Vilobelimab (Anti-Complement C5)

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

• Supplier: Selleck Chemicals
• Product #: A3101
• Sku #: A3101-1mg